Detalhe da pesquisa
1.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res
; 122(3): 479-488, 2018 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208679
2.
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circ Res
; 122(12): 1703-1715, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703749
3.
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Am Heart J
; 201: 54-62, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29910056
4.
Statistical Methods for Cardiovascular Researchers.
Circ Res
; 118(3): 439-53, 2016 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846639
5.
Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study.
Am Heart J
; 183: 24-34, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979038
6.
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic Res Cardiol
; 112(1): 3, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27882430
7.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res
; 116(1): 99-107, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25406300
8.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Am Heart J
; 179: 142-50, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595689
9.
Clinical trials in cardiology: pinnacle or inflection point?
Circ Res
; 114(1): 28-31, 2014 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385506
10.
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circ Res
; 115(10): 867-74, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25136078
11.
Liberation From the P Value's Tyranny.
Circ Res
; 122(8): 1046-1048, 2018 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29650628
12.
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.
Am Heart J
; 168(5): 667-73, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25440794
13.
Consistently Inconsistent-Bone Marrow Mononuclear Stem Cell Therapy Following Acute Myocardial Infarction: A Decade Later.
Circ Res
; 119(3): 404-6, 2016 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458193
14.
DAMASCENE and Meta-Ecological Research: A Bridge Too Far.
Circ Res
; 115(5): 484-7, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006188
15.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811444
16.
Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials.
PLoS One
; 15(8): e0237401, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841277
17.
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC CardioOncol
; 2(4): 581-595, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403362
18.
Reductions in funding for medical research.
JAMA
; 310(8): 854, 2013 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982375
19.
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.
Sci Rep
; 8(1): 4257, 2018 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511207
20.
Reproducibility of CMR in Patients With Cardiac Implantable Electrical Devices: Multicenter CONCERT-HF Trial.
JACC Cardiovasc Imaging
; 15(5): 952-954, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033497